Agilon Health Inc. (AGL) Reports Q1 Loss of $0.04, Revenues Beat

Go back to Agilon Health Inc. (AGL) Reports Q1 Loss of $0.04, Revenues Beat

agilon health Inc (AGL) PT Raised to $43 at BofA Securities

May 27, 2021 8:26 AM EDT

BofA Securities analyst Kevin Fischbeck raised the price target on agilon health Inc (NYSE: AGL) to $43.00 (from $41.00) while maintaining a Buy rating.

Raising ests as strong Q1 should flow through... More